![](https://i2.wp.com/hrnxt.com/wp-content/uploads/2020/08/Workhardt.png?resize=200%2C112&ssl=1)
Wockhardt, the global pharmaceutical and biotechnology major announced that it has entered into an agreement with the UK Government to fill finish COVID-19 vaccines. The manufacturing will be undertaken at CP Pharmaceuticals, a subsidiary of Wockhardt based in Wrexham, North Wales. As per the terms of the agreement the company has reserved manufacturing capacity to…